Evidence map›Paper›PMID 35157274›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Production of Single-Domain Antibodies in Pichia pastoris.

Yusei Matsuzaki, Kaho Kajiwara, Wataru Aoki, Mitsuyoshi Ueda

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Effect ofMolecules (Basel, Switzerland) · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yusei MatsuzakiDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Kaho KajiwaraDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Wataru AokiDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Mitsuyoshi UedaDivision of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. ueda.mitsuyoshi.7w@kyoto-u.ac.jp.
Kyoto University · JPJapan Science and Technology Agency · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-domain antibodies (sdAbs) are binders that consist of a single immunoglobulin domain. SdAbs have gained importance as therapeutics, diagnostic reagents, and research tools. Functional sdAbs are commonly produced in Escherichia coli, which is a simple and widely used host for production of recombinant proteins. However, there are drawbacks of the E. coli expression system, including the potential for misfolded recombinant proteins and pyrogenic contamination with toxic lipopolysaccharides. Pichia pastoris is an alternative host for the production of heterologous proteins because of its high recombinant protein yields and the ability to produce soluble, properly folded proteins without lipopolysaccharide contamination. Here, we describe a method to produce sdAbs in P. pastoris. We present methods for the cloning of sdAb-encoding genes into a P. pastoris expression vector, production and purification of sdAbs, and measurement of sdAb-binding kinetics. Functional sdAbs are easily and routinely obtained using these methods.

Indexed as

SaccharomycetalesSingle-Domain AntibodiesEscherichia coliPichiaRecombinant ProteinsRecombinant ProteinsSingle-Domain AntibodiesPichia pastorisSingle-domain antibodySurface plasmon resonanceVHH (variable domain of heavy chain of heavy chain antibody)Yeast

Identifiers

PMID35157274
OpenAlexW4213002627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.